<!DOCTYPE html>
<html lang="en">
<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title>ISOBM</title>
	<link rel="stylesheet" href="bower_components/bootstrap/dist/css/bootstrap.min.css">
	<link rel="stylesheet" href="bower_components/font-awesome/css/font-awesome.min.css">
	<link rel="stylesheet" href="css/style.css">
	<link rel="stylesheet" href="css/interna.css">
</head>
<body>
	<header>
		<!-- Btn menu Mobile -->
		<div class="btn-menu"><i class="fa fa-bars" aria-hidden="true"></i> menu</div>
		<!-- Menu -->
		<nav class="menu">
			<ul class="list-unstyled">
				<li class="home-menu-roll"><a href="index.html">Home</a></li>
				<li><a href="organization.html">Organization</a></li>
				<li><a href="program.html">Program</a></li>
				<a class="logo-iso-menu" href="index.html"><img src="img/isobm_logo.png" alt=""></a>
				<li><a href="congress.html">Congress Venue</a></li>
				<li><a href="#">Support</a></li>
				<li><a href="contact.html">Contact us</a></li>
				<!-- <li class="dropdown" id="dropdownMenu1" data-toggle="dropdown" >Support
					<ul class="dropdown-menu" aria-labelledby="dropdownMenu1">
					    <li><a href="#">SBPC/ML - Brazilian Society of Clinical Pathology and Laboratory Medicine</a></li>
					    <li><a href="#">Brazilian Laboratory Indicators Program</a></li>
					    <li><a href="#">Brazilian Journal of Pathology and Laboratory Medicine</a></li>
					</ul>
				</li> -->
			</ul>
		</nav>
		<!-- Cebeçalho -->
		<div class="container-fluid cabecalho2 anchor-point">
			<div class="row">
				<div class="pelicula"></div>
				<!-- Conteúdo Cabeçalho -->
				<div class="content-header">
					<a href="index.html">
						<div class="container">
							<div class="row center">
								<div class="logo2">
									<img src="img/isobm_logo.png" alt="">
								</div>
								<h1 class="text-logo-big2">44º congresso anual da isobm</h1>
							</div>
						</div>
					</a>
					<div class="container-fluid title-page">
						<div class="row">
							<div class="curva-2">
								<svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 3620.9 84.8" style="enable-background:new 0 0 3620.9 84.8;" xml:space="preserve" class="brv-2">
									<style type="text/css">
										.st0{fill:#FFFFFF;}
									</style>
									<g id="Camada_1">
										<path id="XMLID_54_" class="st0" d="M0,0c0,0,744.3,83.8,1810.5,83.8C2844.5,83.8,3620.9,0,3620.9,0v98.8H0V0z"/>
									</g>
								</svg>
							</div>
						</div>
						<div class="row">
							<div class="col-md-12">
								<p> Program </p>
							</div>
						</div>
					</div>
				</div>
				<div class="curva">
					<svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 3620.9 84.8" style="enable-background:new 0 0 3620.9 84.8;" xml:space="preserve" class="brv">
						<style type="text/css">
							.st0{fill:#FFFFFF;}
						</style>
						<g id="Camada_1">
							<path id="XMLID_54_" class="st0" d="M0,0c0,0,744.3,83.8,1810.5,83.8C2844.5,83.8,3620.9,0,3620.9,0v98.8H0V0z"/>
						</g>
					</svg>
				</div>
			</div>
		</div>
	</header>
	<main>
	<div class="container crumb">
		<p><a href="index.html">Home</a> > Program</a></p>
	</div>
	<div class="container topicos">
		<article>
			<div class="topics">
				<h3>Preliminary Scientific Program</h3>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;News in clinical guidelines of EGTM – 	European Group on Tumor Markers.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Algorithms in cancer diagnosis – prostatic, lung, unknown primary cancer.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Serum markers for Cutaneous and Uveal Melanoma – new guidelines.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;pplications of tumor markers – screening, early diagnosis of recurrence.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Validation of Cancer Biomarkers – from discover to the clinical use.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Update on tumor markers in hormone-dependent tumors.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New tumor markers – HE-4, PIVKA, ProGRP, DNA circulating.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;HE-4 in endometrial carcinoma.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Update on prostate cancer markers – PSA, PCA3, p2PSA.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Standardization of tumor markers in ovarian cancer – CA 125 and HE-4: ROMA index.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New nucleic acid-based markers in human diseases.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Genetic of cancer – clinical applications in diagnosis and therapy.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Circulating cancer cells – utility in cancer evaluation.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Plasma tumor DNA – from concept to clinical application. </p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Plasma tumor DNA – clinical applications in cancer research.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Epigenetics – from knowledge to clinical applications.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Cancer proteomics and epigenetics – new applications.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Development of epigenetic biomarkers in urological cancer detection.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Screening of colorectal cancer.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Screening of lung cancer.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New therapies in lung cancer – genetics and biomarkers in personalization of lung therapy.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Immunotherapy for management of cancer patients.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Anticancer drugs and new therapeutic strategies.</p>
				<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Cancer and inflammation.</p>
			</div>
		</article>
	</div>
	</main>
	<footer>
		<div class="pelicula"></div>
		<div class="total-footer">
			<div class="ft-normal">
				<div class="txt-footer"><p>© 2017 - 44º congresso anual da isobm | desenvolvido por</p></div>
				<div class="credit-campana"><img src="img/agencia-campana_logo.png" alt=""></p></div>
			</div>
			<div class="ft-mobile">
				<div class="txt-footer"><p>© 2017 - 44º congresso anual da isobm</div>
				<div class="credit-campana"><p>desenvolvido por<img src="img/agencia-campana_logo.png" alt=""></p></div>
			</div>
		</div>
	</footer>
		<script src="bower_components/jquery/dist/jquery.min.js"></script>
		<script src="bower_components/bootstrap/dist/js/bootstrap.min.js"></script>
		<script src="js/functions.js"></script>
</body>
</html>